| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.0088 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |